Furthermore, both arecoline and arecoline N-oxide increase the expression levels of EMT inducers, such as ROS, NOTCH1, and cytokines, and decrease epigenetic protein expression, activating the EMT pathway, and ultimately leading to the development of cancer and its progression to a metastatic stage. This evidence concerns the gene NOTCH1 and cancer.